GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 3, 1997, Pages 304-308

  Jarman, Paul R ^a   Bandmann, O ^a   Marsden, C D ^a   Wood, N W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anticholinergic drugs; Dopa responsive dystonia; GTP cyclohydrolase

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPA; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE CARRIER; DYSTONIA; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; TORSION DYSTONIA;

EID: 0030756449     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.3.304     Document Type: Article

References (25)

1. Fahn S. High dosage anticholinergic therapy in dystonia. Neurology 1983;33:1255-61.
2. Corner BD. Dystonia musculorum deformans in siblings. Treated with Artane (trihexyphenidyl). Proc R Soc Med 1952;45:451-2.
3. Burns CLC. The treatment of torsion spasm in children with trihexyphenidyl (Artane). The Medical Press 1959;241: 148-9.
4. Mucklow ES, Metz HT. Remarkable response to benzhexol hydrochloride (Artane) in children with an unusual progressive striatal syndrome. Dev Med Child Neurol 1964; 6:598-605.
5. Harwood G, Hierons R, Fletcher NA, Marsden CD. Lessons from a remarkable family with dope-responsive dystonia. J Neurol Neurosurg Psychiatry 1994;57:460-3.
6. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991;41:174-81.
7. Segawa M, Ohini K, Itoh S, Aoyama M, Hayakawa H. Childhood basal ganglia disease with remarkable response to L-dopa, hereditary basal ganglia disease with marked diurnal fluctuation. Shinryo (Tokyo) 1971;24:667-72.
8. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal variation. In: Eldridge R, Fahn S, eds. Advances in neurology. New York: Raven Press, 1976:215-33.
9. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol 1988;50:377-84.
10. Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AK. Dopa responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996;5:403-6.
11. Nygaard TG, Wilhelmsen KC, Risch NJ, et al. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 1993;5:386-91.
12. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-42.
13. Fletcher NA, Harding AK, Marsden CD. A genetic study of idiopathic torsion dystonia in the United Kingdom. Brain 1990;113:379-95.
14. Fahn S. Marsden CD, Cain DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, eds Movement disorders 2. London: Butterworths, 1987:332-58.
15. Ozelius L, Kramer PL, Moskowitz CB, et al. Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron 1989;2:1427-34.
16. Kramer PL, de Leon D, Ozelius L, Risch N. Bressman SB, Brin MF. Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol 1990;27: 114-20.
17. Warner TT, Fletcher NA, Davis MB, et al. Linkage analysis in British and French families with idiopathic torsion dystonia. Brain 1993;116:739-44.
18. Ichinose H, Ohye T, Matsuda Y, et al. Characterisation of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem 1995;270:10062-71.
19. Gardella R, Belletti L, Zoppi N, Marini D, Barlati S, Colombi M. Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localista variant of recessive dystrophic epidermolysis bullosa. Am J Hum Genet 1996;59:292-300.
20. Stockler S, Isbrandt D, Hanefeld F, Schmidt B, von Figura K. Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 1996;58:914-22.
21. Akli S, Chelly J, Mezard C, Gandy S, Kahn A, Poenaru L. A 'G' to 'A' mutation at position -1 of a 5′ splice site in a late infantile form of Tay-Sachs disease. J Biol Chem 1990;265: 7324-30.
22. Weil D, D'Alessio M, Ramirez F, et al. Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehers-Danlos syndrome type VII. J Biol Chem 1989;264:16804-9.
23. Hirano M, Tamaru Y, Nagai Y, Ito H, Imai T, Ueno S. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia. Biochem Biophys Res Commun 1995;213:645-51.
24. Furukawa Y, Shimadzu M, Rajput AH, et al. GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann Neurol 1996;39:609-17.
25. Ichinose H, Ohye T, Segawa M, et al. GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci Lett 1995;196:5-8.